Riehen, Switzerland

Franziska E Rohrer

USPTO Granted Patents = 5 



Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Franziska E. Rohrer: Pioneering Innovations in Pharmaceutical Formulations

Introduction

Franziska E. Rohrer, an accomplished inventor based in Riehen, Switzerland, has made significant contributions to the field of pharmaceuticals. With a total of five patents to her name, she is recognized for her innovative work, particularly concerning the solid forms of various compounds.

Latest Patents

One of her most prominent inventions involves the solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine. Her latest patents detail the development of mono-sulfate and hemi-sulfate salts of this compound, alongside crystalline and amorphous forms. These advancements are pivotal for their applications in pharmaceutical formulations, showcasing her dedication to enhancing drug formulation processes.

Career Highlights

Franziska is affiliated with Hoffmann-La Roche Inc., a leading global healthcare company known for its focus on innovation in pharmaceuticals. Her tenure at this esteemed organization has allowed her to work on groundbreaking projects that escalate the efficacy of pharmaceutical applications.

Collaborations

Throughout her career, Franziska has collaborated with esteemed colleagues, including Olaf Grassmann and Regina Moog. These partnerships have not only enriched her professional journey but also contributed to the collective advancement of their projects in the pharmaceutical sector.

Conclusion

Franziska E. Rohrer continues to be a driving force in the field of pharmaceutical innovation. Her patents reflect her innovative spirit and the importance of her work in enhancing drug formulations. As the industry advances, her contributions will undoubtedly have a lasting impact on the development of effective pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…